Charterhouse Capital Partners Invests in PHASTAR

January 5, 2021

Charterhouse Capital Partners has made a growth investment in PHASTAR, a specialist biometrics clinical research organisation (CRO). PHASTAR founder Kevin Kane remains CEO and a significant shareholder; Charterhouse will support the company's geographic expansion and capability growth while Nick Edwards joins as non-executive chair.

Buyers
Charterhouse Capital Partners LLP
Targets
PHASTAR
Location
England, United Kingdom
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.